Regenerative medicine: Technology whose time has come
Regenerative medicine is now Tim Bertram‘s work but in previous chapters of his career, he focused on drugs while working for large pharmaceutical companies such as Pfizer (NYSE:PFE), Smithkline Beecham Pharmaceuticals and Procter & Gamble (NYSE:PG). Bertram left big pharma seven years ago to join Tengion (NASDAQ:TNGN), whose tissue regeneration technology was originally developed at […]